Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis

被引:63
作者
Berthoux, L
Pechoux, C
Ottmann, M
Morel, G
Darlix, JL
机构
[1] ECOLE NORMALE SUPER LYON,UNITE VIROL HUMAINE,INSERM,U412,LABORETRO,F-69364 LYON 07,FRANCE
[2] INST PASTEUR,LAB PATHOL FIBROSES,CNRS U1459,F-69007 LYON,FRANCE
关键词
D O I
10.1128/JVI.71.9.6973-6981.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Nucleocapsid protein NCp7 of human immunodeficiency virus type 1 (HIV-1) is a small basic nucleic acid binding protein containing two zinc fingers of the form (CX2CX4HX4C) and is present at about 2,000 copies inside the viral core, NCp7 molecules are tightly associated with the genomic RNA dimer to form the nucleocapsid, which also includes reverse transcriptase and integrase proteins, In vitro, NCp7 has been shown to bind specifically to HIV-1 RNA inducing NCp7-NCp7 interactions, In the viral context, mutagenesis of amino acid residues in the zinc finger domains showed that NCp7 is responsible for the specific incorporation of genomic RNA into virions and is necessary for correct virion assembly and maturation, In this work, we investigated the consequences of mutating conserved basic residues in the N-terminal region that precedes the first zinc finger, Two of the mutants were poorly infectious and showed only limited, though significant, defects in RNA encapsidation and viral protein maturation, Electron microscopy, together with sucrose gradient analysis, revealed defects in particle core structure and heterogeneity among mutant virions, These defects were associated with strong reduction of proviral DNA synthesis and stability in newly infected cells. Taken together, these data show multiple and probably interdependent implications for the NCp7 protein in both early and late phases of the HIV-1 replicative cycle and emphasize it as a target for antiviral drug development.
引用
收藏
页码:6973 / 6981
页数:9
相关论文
共 48 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   MUTATIONS OF RNA AND PROTEIN SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PACKAGING RESULT IN PRODUCTION OF NONINFECTIOUS VIRUS [J].
ALDOVINI, A ;
YOUNG, RA .
JOURNAL OF VIROLOGY, 1990, 64 (05) :1920-1926
[3]   RETROVIRAL NUCLEOCAPSID DOMAINS MEDIATE THE SPECIFIC RECOGNITION OF GENOMIC VIRAL RNAS BY CHIMERIC GAG POLYPROTEINS DURING RNA PACKAGING IN-VIVO [J].
BERKOWITZ, RD ;
OHAGEN, A ;
HOGLUND, S ;
GOFF, SP .
JOURNAL OF VIROLOGY, 1995, 69 (10) :6445-6456
[4]   Characterization of human immunodeficiency virus type 1 Vif particle incorporation [J].
Camaur, D ;
Trono, D .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6106-6111
[5]   Human immunodeficiency virus type 1 nucleocapsid protein specifically stimulates Mg2+-dependent DNA integration in vitro [J].
Carteau, S ;
Batson, SC ;
Poljak, L ;
Mouscadet, JF ;
DeRocquigny, H ;
Darlix, JL ;
Roques, BP ;
Kas, E ;
Auclair, C .
JOURNAL OF VIROLOGY, 1997, 71 (08) :6225-6229
[6]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[7]   FUSION FROM WITHOUT DIRECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS PARTICLES [J].
CLAVEL, F ;
CHARNEAU, P .
JOURNAL OF VIROLOGY, 1994, 68 (02) :1179-1185
[8]   SPECIFIC BINDING OF HIV-1 NUCLEOCAPSID PROTEIN TO PSI-RNA IN-VITRO REQUIRES N-TERMINAL ZINC-FINGER AND FLANKING BASIC-AMINO-ACID RESIDUES [J].
DANNULL, J ;
SUROVOY, A ;
JUNG, G ;
MOELLING, K .
EMBO JOURNAL, 1994, 13 (07) :1525-1533
[9]  
DARLIX JL, 1993, CR ACAD SCI III-VIE, V316, P763
[10]   CIS ELEMENTS AND TRANS-ACTING FACTORS INVOLVED IN THE RNA DIMERIZATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS HIV-1 [J].
DARLIX, JL ;
GABUS, C ;
NUGEYRE, MT ;
CLAVEL, F ;
BARRESINOUSSI, F .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 216 (03) :689-699